Abstract 3994: Differences in the mutational landscape across race and sex highlight distinct TP53-associated risk in multiple myeloma
Chidiebube Ugwu(Pennsylvania Hospital), Amin Turki(University Hospitals of the Ruhr-University of Bochum), Muluken Megiso(Jefferson Hospital), Elvis Obomanu(Jefferson Einstein Philadelphia Hospital), Nneoma Ubah(Montefiore Medical Center), Tarfa Verinumbe(Albert Einstein College of Medicine), Sam King(Jefferson Hospital), Ariana Neely(Jefferson Hospital), Ana Chachua(Jefferson Hospital), Angimar Uriepero Palma(Pennsylvania Hospital), Alankrita Taneja(Sidney Kimmel Cancer Center)
Cited by 0
Related Papers
Scale-up of antiretroviral treatment access among people living with HIV in Rivers State, Nigeria, 2019--2020
|AIDS|2021|16
Characterizing the Relationship between HIV Peer Support Groups and Internalized Stigma Among People Living with HIV in Nigeria
|AIDS and Behavior|2023|15
Associations of HIV pre-exposure prophylaxis (PrEP) indication, HIV risk perception and unwillingness to use PrEP among people who inject drugs in Baltimore, MD
|Drug and Alcohol Dependence Reports|2024|4
GLP-1 receptor agonist vs aspirin for primary prevention of colorectal cancer: Evidence from a real-world head-to-head comparison.
|Journal of Clinical Oncology|2026|3